Investigating invasive aspergillosis

American Journal of Respiratory and Critical Care Medicine

Volumn 166, Issue 9, 2002, Pages 1159-1160

  Huffnagle, Gary B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EDITORIAL; GENE OVEREXPRESSION; HOST RESISTANCE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENCE; MYCOSIS; PRIORITY JOURNAL;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DISEASE MODELS, ANIMAL; HUMANS; MICE;

EID: 0036841410     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2207009     Document Type: Editorial

References (11)

1. Mehrad B, Wiekowski M, Morrison BE, Chen S-C, Coronel EC, Manfra DJ, Lira SA. Transient lung-specific expression of the chemokine KC improves outcome in invasive aspergillosis. Am J Respir Crit Care Med 2002;166:1263-1268.
2. Rutledge BJ, Rayburn H, Rosenberg R, North RJ, Gladue RP, Corless CL, Rollins BJ. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol 1995;155:4838-4843.
3. Grewal IS, Rutledge BJ, Fiorillo JA, Gu L, Gladue RP, Flavell RA, Rollins BJ. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: Abrogation by a second transgene expressing systemic MCP-1. J Immunol 1997;159:401-408.
4. Gunn MD, Nelken NA, Liao X, Williams LT. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J Immunol 1997;158:376-383.
5. Tsai WC, Strieter RM, Wilkowski JM, Bucknell KA, Burdick MD, Lira SA, Standiford TJ. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J Immunol 1998;161:2435-2440.
6. Glasser SW, Korfhagen TR, Wert SE, Bruno MD, McWilliams KM, Vorbroker DK, Whitsett JA. Genetic element from human surfactant protein SP-C gene confers bronchiolar-alveolar cell specificity in transgenic mice. Am J Physiol 1991;261:L349-L356.
7. Korfhagen TR, Swantz RJ, Wert SE, McCarty JM, Kerlakian CB, Glasser SW, Whitsett JA. Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice. J Clin Invest 1994;93:1691-1699.
8. Baddley JW, Stroud TP, Salzman D, Pappas PG. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001;32:1319-1324.
9. Noverr MN, Toews GB, Huffnagle GB. Production of prostaglandins and leukotrienes by pathogenic fungi. Infect Immun 2002;70:400-402.
10. Warnock DW. Fungal complications of transplantation: Diagnosis, treatment and prevention. J Antimicrob Chemother 1995;36(Suppl B):73-90.
11. Wingard JR, Beals SU, Santos GW, Metz WG, Saral R. Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplant 1987;2:175-181.